Some results have been hidden because they may be inaccessible to you.Show inaccessible results
Nephs: CKD in T2D Treatment | CKD in T2D Amplifies CV Risk
SponsoredView A Cardiorenal Therapy For CKD in T2D That Delays CKD Progression In Patients. Act Now To Reduce Cardiorenal Risk For Your Patients With A Once-Daily Pill.Patient Profiles · FDA-Approved Treatment · Dosing Information · Clinical Efficacy
Manage CKD Progression Risk | Approved For CKD
SponsoredReduce Cardiovascular Death Risk And Slow Chronic Kidney Disease Progression. HCP Website. A Treatment To Slow Progression Of Chronic Kidney Disease. View Clinical Study Results.Guidelines · Safety Info · Patient Support · Patient Savings


Feedback